研究PKLR促進前列腺癌神經內分泌分化之代謝途徑及其治療角色(1/3)

Pharmacology, Toxicology and Pharmaceutical Science

1. Prostate Cancer 100%
2. Pyruvate Kinase 100%
3. Muscarinic Receptor 56%
4. Androgen 50%
5. Protein Kinase B 18%
6. Biological Marker 12%
7. Cholinergic Receptor 12%
8. Cell Receptor 12%
9. Malignant Neoplasm 12%
10. Glucose 12%
11. Transcription Factors 6%
12. Metabolic Disorder 6%
13. Diseases 6%
14. Therapy Resistance 6%
15. Glycolytic Enzyme 6%
16. Zinc Finger Protein 6%
17. G Protein Coupled Receptor 6%
18. Small Cell Lung Cancer 6%
19. Neoplasm 6%
20. Molecular Target 6%
21. Androgen Receptor 6%
22. Carcinogenesis 6%

Biochemistry, Genetics and Molecular Biology

1. Pyruvate Kinase 100%
2. Hemocyte 87%
3. Muscarinic Acetylcholine Receptor 68%
4. Protein Kinase B 18%
5. Cancer Cell 18%
6. Upregulation 12%
7. Glucose Transport 12%
8. Glycolysis 12%
9. Metabolic Pathway 6%
10. Androgen Receptor 6%
11. Enzyme 6%
12. Carcinogenesis 6%
13. Isoform 6%
14. Zinc Finger Motif 6%
15. Transcription Factors 6%
16. G Protein Coupled Receptor 6%
17. Metabolic Disorder 6%
18. BTB/POZ Domain 6%